# Common Drug Interactions in Clinical Practice

## Cardiovascular Drug Interactions

### Warfarin Interactions
**Potentiate Warfarin Effect:**
- Antibiotics: Ciprofloxacin, TMP-SMX
- NSAIDs: Ibuprofen, Naproxen
- Antiarrhythmics: Amiodarone, Propafenone
- Statins: Atorvastatin, Simvastatin (high doses)

**Reduce Warfarin Effect:**
- Anticonvulsants: Carbamazepine, Phenytoin
- Rifampin
- Cholestyramine

### Digoxin Interactions
**Increase Digoxin Levels:**
- Amiodarone
- Verapamil, Diltiazem
- Quinidine
- Erythromycin

**Decrease Digoxin Absorption:**
- Antacids
- Cholestyramine
- Metoclopramide

## Endocrine Drug Interactions

### Oral Contraceptives
**Reduced Efficacy:**
- Antibiotics: Rifampin, Penicillin
- Anticonvulsants: Carbamazepine, Phenobarbital
- St. John's Wort

### Insulin/Oral Hypoglycemics
**Enhanced Hypoglycemia:**
- Beta-blockers (mask symptoms)
- Alcohol
- MAO inhibitors

## Antimicrobial Interactions

### Macrolides (Erythromycin, Clarithromycin)
- Increase statin levels (rhabdomyolysis risk)
- Prolong QT interval with antiarrhythmics
- Increase cyclosporine/tacrolimus levels

### Fluoroquinolones (Ciprofloxacin, Levofloxacin)
- Reduce absorption with antacids, iron, calcium
- Increase theophylline levels
- Prolong QT interval

## CNS Drug Interactions

### SSRIs/SNRIs
**Serotonin Syndrome Risk:**
- Other serotonergic agents (tramadol, triptans)
- MAO inhibitors
- Linezolid

### Benzodiazepines
**Enhanced Sedation:**
- Alcohol
- Opioids
- Antipsychotics

## Monitoring Recommendations
1. **Check INR** within 3-5 days of starting interacting medications
2. **Monitor blood glucose** with insulin dose changes
3. **ECG monitoring** for QT-prolonging drugs
4. **Renal function** monitoring for nephrotoxic combinations
5. **Drug levels** for narrow therapeutic index medications

## Patient Education
- Importance of medication reconciliation
- When to contact healthcare provider
- Signs of toxicity or reduced efficacy


